Quote:
Originally Posted by chet2020
|
The Merck statement is from February.
I have no idea why Merck is ignoring a vast amount of study on the efficacy of Ivermectin. Merck gave up the patent on it and they also have a new competing drug.
Take a minute and read some of the following.
https://bird-group.org/wp-content/up...ting_the.4.pdf
https://bird-group.org/wp-content/up...ting_the.4.pdf
That is from the British researcher group BIRD and is an article from the FLCCC group.
So that's a Meta Analysis.
Quote:
Conclusions: Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to
viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly
|
You can look at the individual studies if you like. Every single study, every single time shows decreased time to viral clearance, reduced mortality at pretty much any stage of the disease and better outcomes. It also works to prevent it in the first place.
I'm not sure why Merck is on about the safety profile. Ivermectin has been dosed north of 4 billion times. The contraindications are well known and the safety profile is _BETTER_ than aspirin. Aspirin kills more people in a year than Ivermectin has killed in the 40+ years it's been dispensed. If you know of a safe drug, compare it to Ivermectin. I'm willing to bet it's not as safe as Ivermectin. I'm not making light of this, drugs can kill if improperly dosed or if they interact with other drugs. Ivermectin has a blood thinner that it can interact with that causes a deficiency. There's one or two other minor things, and that's it. It's an exceptionally safe drug. This is all well known.